Zantac Mass Tort Attorneys in New Hampshire & Maine

Representing Clients Injured by Dangerous Drugs

The FDA has requested that all Ranitidine (Zantac) product be removed from the market because the drug contains high levels of NDMA. Our legal team is taking on clients who have suffered serious injuries after using Zantac and want to be part of the Mass Tort claim against manufacturers. If you or a loved one have suffered harmful or unexpected side-effects after using this product, then please reach out to our experienced lawyers at Shaheen & Gordon, P.A. to discuss your options for recovering the compensation you deserve.

Evidence of Zantac Contamination

In 2019, an online pharmacy testing Zantac detected levels of dimethylformamide (DMF) in blood pressure. DMF can create nitrosamine impurities like N-Nitrosodimethylamine (NDMA), which the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) classify as a likely carcinogen because it can modify DNA. Studies have also shown that NDMA increases the risk of cancer in animal experiments.

Both the WHO and IARC have been recommending recalls for drugs that are found to contain unacceptable levels of these contaminants since 2018.

In 2019, the FDA published a safety communication warning that some ranitidine medicines, including Zantac, had tested positive for NDMA. Not long after the FDA issued the warning, Sandoz recalled 14 lots of its generic version of ranitidine hydrochloride capsules upon confirmation that the NDMA contamination levels exceed safety the FDA’s established permissible daily intake of 96 ng. Although generic drug manufacturers like Glaxo-Smith-Kline and Dr. Reddy’s Laboratories halted shipments of their ranitidine products, they didn’t implement any recalls.

What Injuries Are Associated With Zantac?

The following injuries are associated with Zantac and other generic forms of ranitidine:

• Bladder cancer
• Brain cancer
• Colon and rectal cancer
• Esophageal cancer
• Intestinal cancer
• Kidney cancer
• Liver cancer
• Ovarian cancer
• Pancreatic cancer
• Prostate cancer
• Stomach cancer
• Testicular cancer
• Uterine cancer

Take Legal Action Today

A class-action lawsuit against Zantac manufacturer, Sanoti-Aventis LLC, and former owner of the rights to Zantac, Boehringer Ingelheim, was filed 2019. The lawsuit alleges that the defendants failed to warn healthcare providers and the public about the dangers of taking Zantac by not revealing that it could produce NDMA in the human body.

If you or a loved one have sustained any of the injuries listed above after using Zantac or other generic ranitidine medicines, please don’t hesitate to reach out to our personal injury team at Shaheen & Gordon, P.A. to discuss your situation so we can determine if you are eligible to join the Mass Tort lawsuit against negligent parties. When you choose our firm to represent you, we will stand by your side each step of the way to make sure your best interests are protected.

Give us a call today at (888) 801-9916 to schedule your case consultation with a compassionate legal advocate at our firm.